ICBMT 2024. ICBMT 2024. THE 8th INTERNATIONAL CONGRESS OF BMT 2024. THE 29th ANNUAL CONGRESS OF KSBMT.

Moving Forward into the New Era of HSCT and Cellular Therapy

SEPTEMBER 26(Thu) - 28(Sat), 2024. BEXCO, BUSAN, KOREA
HOME

Scientific Program

SELECT AND VIEW SESSIONS OF YOUR CHOICE
Search

Joint Symposium 5

Sep. 28 (Sat), 09:00-10:30 		Room A
(2F)
Chair(s) Seong Kyu Park (Soonchunhyang University College of Medicine)
Steve Oh (Independent Cell Therapy Leader)
  • Steve Oh

    09:00-09:30

    Supercharging the Delivery of Gene Therapies with Red Blood Cells

    Steve Oh

    Independent Cell Therapy Leader, Singapore

  • Joanne Mountford

    09:30-10:00

    Technical Issues and Hurdles of In Vitro Derived Blood Products

    Joanne Mountford

    Scottish National Blood Transfusion Service, UK

  • Eun Jung Baek

    10:00-10:30

    Manufacturing Blood Products Derived from Stem Cells

    Eun Jung Baek

    Department of Laboratory Medicine, Hanyang University College of Medicine; ArtBlood Inc., Korea

Scientific Session 11

Sep. 28 (Sat), 09:00-10:30 		Room B
(2F)
Chair(s) Deog-Yeon Jo (Chungnam National University College of Medicine)
Won-Sik Lee (Inje University College of Medicine)
  • Sejin Im

    09:00-09:30

    Defining a TCF1-Expressing Progenitor Allogeneic CD8+ T Cell Subset in Acute Graft-versus-Host Disease

    Sejin Im

    Department of Immunology, Sungkyunkwan University School of Medicine, Korea

  • Daniel Wolff

    09:30-10:00

    CSF-1R Inhibitor (Axatilimab) for Chronic GVHD

    Daniel Wolff

    University Hospital Regensburg, Germany

  • Tae Kon Kim

    10:00-10:30

    PD-1H/VISTA Expressed on Host Myeloid Cells Limits Acute Graft-versus-Host Disease

    Tae Kon Kim

    Vanderbilt University, USA

Scientific Session 12

Sep. 28 (Sat), 09:00-10:30 		Room C
(1F)
Chair(s) Seok Jin Kim (Sungkyunkwan University School of Medicine)
Byung-Su Kim (The Catholic University of Korea)
  • Stanley Riddell

    09:00-09:30

    Conquering Tumor Heterogeneity with Engineered T Cell Therapies

    Stanley Riddell

    Fred Hutchinson Cancer Center, USA

  • Anna Sureda

    09:30-10:00

    Changing the Treatment Landscape with CART Cells in Patients with B-Cell Lymphomas

    Anna Sureda

    Catalan Institute of Oncology, Spain

  • Hyungwoo Cho

    10:00-10:30

    Practical Challenges in Korea

    Hyungwoo Cho

    University of Ulsan College of Medicine, Korea

Joint Symposium 6

Sep. 28 (Sat), 10:40-11:40 		Room A
(2F)
Chair(s) Jae Ho Yoon (The Catholic University of Korea)
Elifcan Aladag Karakulak (Hacettepe University)
  • Elifcan Aladag Karakulak

    10:40-11:10

    Prevention and Treatment Strategy of Acute GVHD in Türkiye

    Elifcan Aladag Karakulak

    Hacettepe University, Türkiye

Scientific Session 13

Sep. 28 (Sat), 10:40-12:10 		Room B
(2F)
Chair(s) Keon Hee Yoo (Sungkyunkwan University School of Medicine)
Jae Wook Lee (The Catholic University of Korea)
  • Heather J. Symons

    10:40-11:10

    PTCy-Based Haploidentical HSCT in Pediatric Leukemia

    Heather J. Symons

    Johns Hopkins University School of Medicine, USA

  • Peter Bader

    11:10-11:40

    Optimizing Conditioning for Children and Adolescents with ALL

    Peter Bader

    Goethe University Frankfurt, Germany

  • Jae Wook Lee

    11:40-12:10

    PTCy-Based Haploidentical HSCT for Pediatric AML

    Jae Wook Lee

    The Catholic University of Korea, Korea

Nursing Session 2

Sep. 28 (Sat), 10:40-12:10 		Room C
(1F)
Chair(s) EunJung Joo (National Cancer Center)
  • Chin Kook Rhee

    10:40-11:25

    Management of Pulmonary Complication

    Chin Kook Rhee

    Department of Internal Medicine, The Catholic University of Korea, Korea

  • Kwan-Sik Seo

    11:25-12:10

    Health Rehabilitation Program for HSCT Patients

    Kwan-Sik Seo

    Department of Rehabilitation Medicine, Seoul National University College of Medicine, Korea